Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.38 +0.10 (+0.06%)
Streaming Delayed Price Updated: 3:08 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,241,335
Open 154.86
Bid (Size) 154.37 (1)
Ask (Size) 154.39 (4)
Prev. Close 154.28
Today's Range 153.71 - 154.86
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Value Stocks to Buy and Hold for a Decade of Dominance
Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities. 
Via InvestorPlace
3 Cheap Healthcare Stocks to Buy Now: May 2024
Healthcare is cheaper than the market and has secular growth tailwinds, meaning these cheap healthcare stocks have upside. 
Via InvestorPlace

Performance

YTD
-3.49%
-3.49%
1 Month
+6.87%
+6.87%
3 Month
-2.24%
-2.24%
6 Month
+2.85%
+2.85%
1 Year
-2.90%
-2.90%

More News

Read More
3 Robotics and Automation Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
Why NYSE:JNJ is a Top Pick for Dividend Investors.
Via Chartmill
Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market
Via InvestorPlace
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Via Benzinga
1 Passive Income Vehicle Every Investor Should Own
Via The Motley Fool
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Via Benzinga
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
From Johnson & Johnson
Via Business Wire
Consumer Staples Standouts: 3 Defensive Gems to Safeguard Your Portfolio
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
1 No-Brainer Growth Stock to Buy and Hold for 10 Years
Via The Motley Fool
Best Foundational Stocks
Via Talk Markets
J&J: A Healthy Dose Of Income And Growth
Via Talk Markets
Johnson & Johnson's Subsidiary Discontinues Some Megadyne Electrodes For Pediatric Use
Via Benzinga
Exposures Product Safety
Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock
Via InvestorPlace
2 Supercharged Dividend Stocks to Buy and Hold for Years
Via The Motley Fool
The 7 Most Undervalued Stocks With Strong Fundamentals to Buy in May 2024
Via InvestorPlace
7 Reliable Dividend Stocks to Keep Your Portfolio Upright
Via InvestorPlace
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Via The Motley Fool
The 3 Best Mutual Funds to Buy in May 2024
Via InvestorPlace
The 3 Most Undervalued Stocks to Buy in May 2024
Via InvestorPlace
3 Biotech Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
Prediction: 3 Sensational Stocks That'll Be Worth Far More Than Tesla 2 Years From Now
Via The Motley Fool
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
Via FinancialNewsMedia
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.